Recent Updates
Recently added Catalysts
STVN Positive Sentiment

Stevanato Group to Participate in Two Upcoming Investor Conferences

Key Takeaway: Stevanato Group S.p.A. (NYSE: STVN) has announced its participation in two significant investor conferences. The first will be held on September 15 at the Morgan Stanley Annual Global Healthcare Conference in New York, followed by the BofA Global Healthcare Conference on September 22. These events aim to strengthen investor relations and showcase the company's offerings.
Price reaction · baseline $20.32 (2026-09-08 close) · hit after-hours · clean, no other STVN news in the window
day 0 close · peak
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Stevanato Group is actively engaging with investors.
  • Participation in major healthcare conferences enhances visibility.
  • The company is recognized as a leader in drug delivery solutions.

Full Press Release Details

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences:
• Tuesday, September 15, at 1:50 p.m. (ET) – Morgan Stanley Annual Global Healthcare Conference, New York, NY
• Tuesday, September 22, at 8:25 – 9:05 a.m. (GMT) – BofA Global Healthcare Conference, London, UK
A live webcast for each event will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients.
For more information, please visit: www.stevanatogroup.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20260908397502/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles lisa.miles@stevanatogroup.com Giacomo Guiducci giacomo.guiducci@stevanatogroup.com
Source: Stevanato Group S.p.A.
Released September 8, 2026

Frequently Asked Questions

When will Stevanato Group participate in the conferences?

Stevanato Group will participate on September 15 and September 22, 2023.

What is the location of the Morgan Stanley conference?

The Morgan Stanley Annual Global Healthcare Conference will be in New York, NY.

What is the purpose of these investor conferences?

The conferences aim to enhance investor relations and showcase Stevanato's solutions.

What time is Stevanato's presentation at the BofA conference?

Stevanato's presentation at the BofA conference is scheduled from 8:25 to 9:05 a.m. GMT.

Last updated: Sep 8, 2026